Literature DB >> 9145889

Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3.

X Liao1, R E Hancock.   

Abstract

By using a broad-host-range vector, pUCP27, the Pseudomonas aeruginosa and Escherichia coli pbpB genes, which encode penicillin-binding protein 3 (PBP3), were separately overexpressed in a P. aeruginosa strain, PAO4089, that is deficient in producing chromosomal beta-lactamase. Susceptibility studies indicated that overproduction of the P. aeruginosa PBP3 in PAO4089 resulted in twofold-increased resistance to aztreonam, fourfold-increased resistance to cefepime and cefsulodin, and eightfold-increased resistance to ceftazidime, whereas overproduction of the P. aeruginosa PBP3 in PAO4089 did not affect susceptibility to PBP1-targeted cephaloridine or PBP2-targeted imipenem. Similar results were obtained with PAO4089 overproducing E. coli PBP3, with the exception that there was no influence on the MICs or minimal bactericidal concentrations of cefsulodin and cefepime, which have very low affinities for E. coli PBP3. These data are consistent with the conclusion that PBP3 has to achieve a certain level of saturation, with beta-lactams targeted to this protein, to result in cell inhibition or death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145889      PMCID: PMC163870     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.

Authors:  H Nikaido; S Normark
Journal:  Mol Microbiol       Date:  1987-07       Impact factor: 3.501

2.  Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9.

Authors:  B G Spratt; P J Hedge; S te Heesen; A Edelman; J K Broome-Smith
Journal:  Gene       Date:  1986       Impact factor: 3.688

3.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

4.  Physical mapping of 32 genetic markers on the Pseudomonas aeruginosa PAO1 chromosome.

Authors:  Xiaowen Liao; Isabelle Charlebois; Catherine Ouellet; Marie-Josée Morency; Ken Dewar; Jeff Lightfoot; Jennifer Foster; Richard Siehnel; Herbert Schweizer; Joseph S Lam; Robert E W Hancock; Roger C Levesque
Journal:  Microbiology (Reading)       Date:  1996-01       Impact factor: 2.777

5.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

6.  A method for construction of bacterial hosts for lac-based cloning and expression vectors: alpha-complementation and regulated expression.

Authors:  H P Schweizer
Journal:  Biotechniques       Date:  1994-09       Impact factor: 1.993

7.  Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis.

Authors:  T R Parr; L Chan; A S Bayer
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

8.  Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams.

Authors:  N Watanabe; K Katsu
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

9.  beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.

Authors:  A J Godfrey; L E Bryan; H R Rabin
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3.

Authors:  X Liao; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  10 in total

1.  AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.

Authors:  Daniel J Wolter; Nancy D Hanson; Philip D Lister
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy In Vivo.

Authors:  Kathryn McLean; Duankun Lee; Elizabeth A Holmes; Kelsi Penewit; Adam Waalkes; Mingxin Ren; Samuel A Lee; Joseph Gasper; Colin Manoil; Stephen J Salipante
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

3.  Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa.

Authors:  Seungil Han; Richard P Zaniewski; Eric S Marr; Brian M Lacey; Andrew P Tomaras; Artem Evdokimov; J Richard Miller; Veerabahu Shanmugasundaram
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

4.  Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.

Authors:  Yuanyuan Jiao; Bartolome Moya; Mong-Jen Chen; Alexandre P Zavascki; Hsinyin Tsai; Xun Tao; Dhruvitkumar S Sutaria; Arnold Louie; John D Boyce; Deanna Deveson Lucas; Tae Hwan Kim; Brian T Tsuji; Robert A Bonomo; George L Drusano; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

5.  Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa.

Authors:  Wei Chen; Yong-Mei Zhang; Christopher Davies
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data.

Authors:  Veronica N Kos; Robert E McLaughlin; Humphrey A Gardner
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

7.  Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.

Authors:  L Vettoretti; N Floret; D Hocquet; B Dehecq; P Plésiat; D Talon; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-07       Impact factor: 3.267

8.  Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and antibiotic-bound forms.

Authors:  Sarah Sainsbury; Louise Bird; Vincenzo Rao; Sharon M Shepherd; David I Stuart; William N Hunter; Raymond J Owens; Jingshan Ren
Journal:  J Mol Biol       Date:  2010-10-23       Impact factor: 5.469

9.  Evolution of Burkholderia pseudomallei in recurrent melioidosis.

Authors:  Hillary S Hayden; Regina Lim; Mitchell J Brittnacher; Elizabeth H Sims; Elizabeth R Ramage; Christine Fong; Zaining Wu; Eva Crist; Jean Chang; Yang Zhou; Matthew Radey; Laurence Rohmer; Eric Haugen; Will Gillett; Vanaporn Wuthiekanun; Sharon J Peacock; Rajinder Kaul; Samuel I Miller; Colin Manoil; Michael A Jacobs
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

Review 10.  Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy.

Authors:  Alireza FakhriRavari; Brenda Simiyu; Taylor Morrisette; Yewande Dayo; Jacinda C Abdul-Mutakabbir
Journal:  Drugs Context       Date:  2022-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.